Tag

sequenziario

5 minuti di lettura

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

(Adnkronos) – APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS for adult and pediatric patients 12 years of age

Immediapress

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

(Adnkronos) – ZUG, Switzerland, April 27, 2023 /PRNewswire/ — Taiho Oncology Europe GmbH and Taiho Pharmaceutical Co., Ltd. announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

Immediapress

(Adnkronos) – TAMPA, Fla., May 1, 2023 /PRNewswire/ — The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

Immediapress

(Adnkronos) – TAMPA, Fla., Feb. 13, 2023 /PRNewswire/ — Concept Medical Inc. (CMI), on 9thFebruary 2023, received the Investigational Device Exemption (IDE) from the US FDA,

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

mercoledì, 20 Dicembre 2023

Immediapress

(Adnkronos) – Collective effort to optimize and standardize treatment practices now covers more than 90% of adult cancer incidences plus an increasing number of pediatric diseases. PLYMOUTH MEETING, Pa., Dec. 20, 2023

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

lunedì, 13 Novembre 2023

Immediapress

(Adnkronos) – Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition ZUG, Switzerland and PARIS, Nov. 13, 2023

UZ Brussel PERT and Aidoc Pave the Way as First Hospital in Europe for Expedited Treatment of Pulmonary Embolism with AI

giovedì, 26 Ottobre 2023

Immediapress

(Adnkronos) – Aidoc AI identifies suspected cases of acute pulmonary embolism, enabling rapid care coordination and treatment cross-functionally with their PE Response Team LONDON, Oct. 26, 2023 /PRNewswire/ — Aidoc today announced

U.S. FDA GRANTS LIPOGEMS® SECOND IDE APPROVAL FOR A CLINICAL TRIAL ON THE TREATMENT FOR KNEE OA

mercoledì, 4 Ottobre 2023

Immediapress

(Adnkronos) – ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study for the use of MicroFat for the treatment

Englobe partners with OPTEL to ensure full global traceability of its contaminated soil treatment activities

lunedì, 2 Ottobre 2023

Immediapress

(Adnkronos) – QUEBEC, Oct. 2, 2023 /PRNewswire/ — Today, Englobe, the global pioneer in contaminated soil treatment and processing, announces its partnership with OPTEL to ensure full regulatory traceability of its soils

Advancing Cancer Treatment: Leo Cancer Care and THERYQ Collaborate on Innovative FLASHDEEP Patient Positioning

domenica, 1 Ottobre 2023

Immediapress

(Adnkronos) – PEYNIER, France, Oct. 1, 2023 /PRNewswire/ — The collaboration between Leo Cancer Care and THERYQ brings together the extensive expertise of both organizations to create an integrated solution that promises

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

venerdì, 22 Settembre 2023

Immediapress

(Adnkronos) – ZURICH, Sept. 22, 2023 /PRNewswire/ — Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of lanadelumab

Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients

lunedì, 18 Settembre 2023

Immediapress

(Adnkronos) – HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ — During the 23th ERS International Congress on September 11, Broncus announced long-term follow-up data about Bronchoscopic Thermal Vapor Ablation (BTVA) treatment using InterVapor®,

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

venerdì, 21 Luglio 2023

Immediapress

(Adnkronos) – SAN DIEGO, July 21, 2023 /PRNewswire/ — Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

giovedì, 20 Luglio 2023

Immediapress

(Adnkronos) – AMSTERDAM, July 20, 2023 /PRNewswire/ — New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2023 covered the breadth of Alzheimer’s disease and dementia research, including advancements in treatment, early and

1 2 Avanti

sequenziario

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

CHMP ISSUES POSITIVE OPINION FOR FUTIBATINIB FOR THE TREATMENT OF ADULTS WITH CHOLANGIOCARCINOMA

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Updates Resources for Sixth Year

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

UZ Brussel PERT and Aidoc Pave the Way as First Hospital in Europe for Expedited Treatment of Pulmonary Embolism with AI

U.S. FDA GRANTS LIPOGEMS® SECOND IDE APPROVAL FOR A CLINICAL TRIAL ON THE TREATMENT FOR KNEE OA

Englobe partners with OPTEL to ensure full global traceability of its contaminated soil treatment activities

Advancing Cancer Treatment: Leo Cancer Care and THERYQ Collaborate on Innovative FLASHDEEP Patient Positioning

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

Primo piano

CdM approva decreto urgente per autotrasporto, agricoltura e pesca. Meloni: “Non tolleriamo intimidazioni” | Video

Il prete che ha mostrato il dito medio ai ragazzi durante i disordini a Milano: «Pentito? No, ho solo risposto»

Italia-Spagna, la sospensione di Schengen non sarà rinnovata

Blocco Tir, governo “sblocca” in Sicilia e Calabria, ma il Golfo di Napoli a rischio isolamento

Dopo gli scontri: cosa prevede il decreto e quali poteri hanno i militari

Sponsor

Suggerimenti

sequenziario

Primo piano

Sponsor